| http://dbpedia.org/ontology/abstract
|
Ipsen — французская фармацевтическая компа … Ipsen — французская фармацевтическая компания. Штаб-квартира расположена в Булонь-Бийанкур (пригород Парижа, Франция). Специализируется на трех терапевтических областях: онкология, нейробиология и редкие заболевания. Компания продает более 20 лекарств в 115 странах. Семья Бофур, которая занимает 42-е место среди самых богатых семей Франции, по-прежнему владеет 57 % акций и 73 % голосов, а два её члена (внуки основателя Анн Бофур и Анри Бофур) являются членами совета директоров.Бофур) являются членами совета директоров.
, Ipsen adalah perusahaan farmasi Prancis ya … Ipsen adalah perusahaan farmasi Prancis yang berbasis di Paris, Prancis. Perusahaan ini mengkhususkan diri dalam tiga bidang terapi: onkologi, ilmu saraf, dan penyakit langka. Ini diperdagangkan secara publik di Euronext Paris sebagai bagian dari indeks SBF 120 (2005). Ipsen, didirikan oleh Henri Beaufour pada tahun 1929, memiliki lebih dari 5.700 karyawan di seluruh dunia dan memasarkan lebih dari 20 obat di 115 negara.masarkan lebih dari 20 obat di 115 negara.
, Ipsen es una empresa farmacéutica francesa … Ipsen es una empresa farmacéutica francesa con sede en París, Francia. Se especializa en tres áreas de terapia: oncología, neurociencia y enfermedades raras. Se cotiza en bolsa en Euronext Paris como parte del índice SBF 120 (2005). Ipsen, fundada por Henri Beaufour en 1929, tiene más de 5.700 empleados en todo el mundo y comercializa más de 20 medicamentos en 115 países.iza más de 20 medicamentos en 115 países.
, Ipsen é uma empresa farmacêutica francesa … Ipsen é uma empresa farmacêutica francesa com sede em Paris, França. Fundamentalmente, desenvolve e comercializa medicamentos usados em oncologia, endocrinologia e no tratamento das doenças neuromusculares. A Ipsen atuava no mercado brasileiro por meio de parceiros distribuidores dos seus medicamentos, contudo, em 2009 a empresa decidiu abrir sua filial em São Paulo visando estreitar os lanços com seus clientes.ndo estreitar os lanços com seus clientes.
, Ipsen est un groupe biopharmaceutique fran … Ipsen est un groupe biopharmaceutique français fondé en 1929, spécialisé en oncologie, en neurosciences, dans les maladies rares, ainsi qu'en santé familiale. L'entreprise réalise un chiffre d’affaires de 2,6 milliards d’euros (2019) et commercialise une vingtaine de médicaments dans 115 pays. Il réunit plus de 5 700 salariés dans le monde. IPSEN est l'acronyme de « Institut des produits de synthèse et d'extraction naturelle ». Les activités actuelles du groupe sont davantage diversifiées qu'à l'origine.ont davantage diversifiées qu'à l'origine.
, Ipsen è una società farmaceutica francese … Ipsen è una società farmaceutica francese con sede a Parigi, Francia. È specializzato in tre aree terapeutiche: oncologia, neuroscienze e malattie rare. È quotato in borsa su Euronext Paris come parte dell'indice SBF 120 (2005). Ipsen, fondata da Henri Beaufour nel 1929, ha più di 5.700 dipendenti in tutto il mondo e commercializza più di 20 farmaci in 115 paesi.ercializza più di 20 farmaci in 115 paesi.
, Ipsen Group ist ein global agierendes biop … Ipsen Group ist ein global agierendes biopharmazeutisches Unternehmen. Das Unternehmen wurde 1929 in Dreux, Frankreich gegründet. Der heutige Firmensitz befindet sich in Paris. Der Deutschlandsitz in München. Das Unternehmen ist im Familienbesitz der Familie Beaufour und beschäftigt rund 4.000 Mitarbeiter. Zu den von Ipsen Group hergestellten Medikamenten gehören unter anderem in der
* Onkologie – Cabometyx und Cometriq (Cabozantinib), Decapeptyl
* Endokrinologie – Somatuline (Lanretoid, ein Somatostatin-Analogon), NutropinAq (Somatropin), Testim (Testosteron-Gel)
* neuromuskularen Störungen – Dysport (Botulinumtoxin A).en Störungen – Dysport (Botulinumtoxin A).
, Ipsen is a French pharmaceutical company h … Ipsen is a French pharmaceutical company headquartered in Paris, France. It is specialized in oncology, neuroscience and rare diseases. It is publicly traded on the Euronext Paris as part of the SBF 120 index (2005). Ipsen, founded by Henri Beaufour in 1929, has 5,700 employees worldwide, and markets 20 drugs in 115 countries. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors.i Beaufour, sit on its board of directors.
, イプセン（フランス語: Ipsen S.A.）は、フランス・パリに本社を置き、世界20カ国以上に拠点を持つ製薬企業である。主に腫瘍、内分泌、神経筋障害の処置に使用される薬品を開発し販売している。ユーロネクスト・パリに上場している。
|
| http://dbpedia.org/ontology/foundingYear
|
1929
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Pharmaceutical +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Marc_de_Garidel +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Paris +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
5700
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Cough +
, http://dbpedia.org/resource/Gastroenterology +
, http://dbpedia.org/resource/Neuroscience +
, http://dbpedia.org/resource/Oncology +
, http://dbpedia.org/resource/Rare_diseases +
, http://dbpedia.org/resource/Pain +
, http://dbpedia.org/resource/Cognitive_disorder +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Ipsen_logo.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.ipsen.com +
, https://www.ipsen.com/en/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
4937414
|
| http://dbpedia.org/ontology/wikiPageLength
|
10165
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1123865604
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/SBF_120 +
, http://dbpedia.org/resource/Oncology +
, http://dbpedia.org/resource/Gastroenterology +
, http://dbpedia.org/resource/French_Alternative_Energies_and_Atomic_Energy_Commission +
, http://dbpedia.org/resource/Milton_Park +
, http://dbpedia.org/resource/Fondation_de_France +
, http://dbpedia.org/resource/Category:Companies_listed_on_Euronext_Paris +
, http://dbpedia.org/resource/Euronext_Paris +
, http://dbpedia.org/resource/Category:Manufacturing_companies_based_in_Paris +
, http://dbpedia.org/resource/Galderma +
, http://dbpedia.org/resource/Research_and_development +
, http://dbpedia.org/resource/Pharmaceutical +
, http://dbpedia.org/resource/Blood_vessel +
, http://dbpedia.org/resource/Henri_Beaufour +
, http://dbpedia.org/resource/United_Kingdom +
, http://dbpedia.org/resource/Pain +
, http://dbpedia.org/resource/Paris +
, http://dbpedia.org/resource/Rare_diseases +
, http://dbpedia.org/resource/Category:French_companies_established_in_1929 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1929 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_France +
, http://dbpedia.org/resource/CAC_Mid_60 +
, http://dbpedia.org/resource/Cabozantinib +
, http://dbpedia.org/resource/Multiple_sclerosis +
, http://dbpedia.org/resource/University_of_Rennes_1 +
, http://dbpedia.org/resource/Indigestion +
, http://dbpedia.org/resource/Subsidiary +
, http://dbpedia.org/resource/Cognitive_disorder +
, http://dbpedia.org/resource/Cambridge%2C_Massachusetts +
, http://dbpedia.org/resource/Pharmaceutical_company +
, http://dbpedia.org/resource/Diosmectite +
, http://dbpedia.org/resource/French_National_Centre_for_Scientific_Research +
, http://dbpedia.org/resource/Massachusetts +
, http://dbpedia.org/resource/Irinotecan +
, http://dbpedia.org/resource/Neuroscience +
, http://dbpedia.org/resource/China +
, http://dbpedia.org/resource/Merrimack_Pharmaceuticals +
, http://dbpedia.org/resource/Marc_de_Garidel +
, http://dbpedia.org/resource/Russia +
, http://dbpedia.org/resource/European_Commission +
, http://dbpedia.org/resource/Oxford +
, http://dbpedia.org/resource/Anne_Beaufour +
, http://dbpedia.org/resource/European_Society_for_Medical_Oncology +
, http://dbpedia.org/resource/Dreux +
, http://dbpedia.org/resource/Cough +
, http://dbpedia.org/resource/United_States +
|
| http://dbpedia.org/property/certain
|
yes
|
| http://dbpedia.org/property/date
|
July 2019
|
| http://dbpedia.org/property/foundation
|
1929
|
| http://dbpedia.org/property/homepage
|
https://www.ipsen.com +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Pharmaceutical +
|
| http://dbpedia.org/property/keyPeople
|
http://dbpedia.org/resource/Marc_de_Garidel +
, David Loew
|
| http://dbpedia.org/property/location
|
Paris, France
|
| http://dbpedia.org/property/logo
|
Ipsen logo.svg
|
| http://dbpedia.org/property/name
|
Ipsen S.A.
|
| http://dbpedia.org/property/numEmployees
|
5700
|
| http://dbpedia.org/property/products
|
*Targeted therapeutic areas : oncology, neuroscience and rare diseases
*Consumer healthcare: gastroenterology, cognitive disorders, pain, cough and cold
|
| http://dbpedia.org/property/tradedAs
|
http://dbpedia.org/resource/CAC_Mid_60 +
, Euronext:IPN
|
| http://dbpedia.org/property/type
|
Public
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Self-published_inline +
, http://dbpedia.org/resource/Template:EngvarB +
, http://dbpedia.org/resource/Template:About +
, http://dbpedia.org/resource/Template:Official +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:CAC_Mid_60 +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Citation_needed +
, http://dbpedia.org/resource/Template:Authority_control +
|
| http://dbpedia.org/property/wordnet type
|
http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1 +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:French_companies_established_in_1929 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1929 +
, http://dbpedia.org/resource/Category:Companies_listed_on_Euronext_Paris +
, http://dbpedia.org/resource/Category:Manufacturing_companies_based_in_Paris +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_France +
|
| http://schema.org/sameAs
|
http://viaf.org/viaf/236582255 +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.476474.2 +
, http://www.grid.ac/institutes/grid.476475.3 +
, http://www.grid.ac/institutes/grid.473168.f +
, http://www.grid.ac/institutes/grid.438365.f +
, http://www.grid.ac/institutes/grid.476480.9 +
, http://www.grid.ac/institutes/grid.476482.b +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Ipsen?oldid=1123865604&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Ipsen_logo.svg +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.ipsen.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Ipsen +
|
| http://xmlns.com/foaf/0.1/name
|
Ipsen S.A.
|
| owl:sameAs |
http://pt.dbpedia.org/resource/Ipsen +
, http://fa.dbpedia.org/resource/%D8%A7%DB%8C%D9%BE%D8%B3%D9%86 +
, http://rdf.freebase.com/ns/m.025t90v +
, http://d-nb.info/gnd/4785808-4 +
, http://dbpedia.org/resource/Ipsen +
, http://es.dbpedia.org/resource/Ipsen +
, http://ja.dbpedia.org/resource/%E3%82%A4%E3%83%97%E3%82%BB%E3%83%B3_%28%E8%A3%BD%E8%96%AC%E4%BC%9A%E7%A4%BE%29 +
, http://www.wikidata.org/entity/Q111546 +
, http://yago-knowledge.org/resource/Ipsen +
, http://de.dbpedia.org/resource/Ipsen_Group +
, http://it.dbpedia.org/resource/Ipsen +
, http://id.dbpedia.org/resource/Ipsen +
, http://ms.dbpedia.org/resource/Ipsen +
, http://d-nb.info/gnd/2117601-2 +
, http://ru.dbpedia.org/resource/Ipsen +
, http://fr.dbpedia.org/resource/Ipsen +
, http://viaf.org/viaf/148436614 +
, https://global.dbpedia.org/id/BUg4 +
, http://viaf.org/viaf/236582255 +
, http://th.dbpedia.org/resource/%E0%B8%AD%E0%B8%B4%E0%B8%9B%E0%B9%80%E0%B8%8B%E0%B8%99 +
|
| rdf:type |
http://schema.org/Organization +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfTheUnitedKingdom +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesEstablishedIn1929 +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1929 +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompanies +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfFrance +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInParis +
, http://dbpedia.org/class/yago/Abstraction100002137 +
|
| rdfs:comment |
Ipsen est un groupe biopharmaceutique fran … Ipsen est un groupe biopharmaceutique français fondé en 1929, spécialisé en oncologie, en neurosciences, dans les maladies rares, ainsi qu'en santé familiale. L'entreprise réalise un chiffre d’affaires de 2,6 milliards d’euros (2019) et commercialise une vingtaine de médicaments dans 115 pays. Il réunit plus de 5 700 salariés dans le monde. IPSEN est l'acronyme de « Institut des produits de synthèse et d'extraction naturelle ». Les activités actuelles du groupe sont davantage diversifiées qu'à l'origine.ont davantage diversifiées qu'à l'origine.
, Ipsen è una società farmaceutica francese … Ipsen è una società farmaceutica francese con sede a Parigi, Francia. È specializzato in tre aree terapeutiche: oncologia, neuroscienze e malattie rare. È quotato in borsa su Euronext Paris come parte dell'indice SBF 120 (2005). Ipsen, fondata da Henri Beaufour nel 1929, ha più di 5.700 dipendenti in tutto il mondo e commercializza più di 20 farmaci in 115 paesi.ercializza più di 20 farmaci in 115 paesi.
, Ipsen is a French pharmaceutical company h … Ipsen is a French pharmaceutical company headquartered in Paris, France. It is specialized in oncology, neuroscience and rare diseases. It is publicly traded on the Euronext Paris as part of the SBF 120 index (2005). Ipsen, founded by Henri Beaufour in 1929, has 5,700 employees worldwide, and markets 20 drugs in 115 countries. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors.i Beaufour, sit on its board of directors.
, イプセン（フランス語: Ipsen S.A.）は、フランス・パリに本社を置き、世界20カ国以上に拠点を持つ製薬企業である。主に腫瘍、内分泌、神経筋障害の処置に使用される薬品を開発し販売している。ユーロネクスト・パリに上場している。
, Ipsen Group ist ein global agierendes biop … Ipsen Group ist ein global agierendes biopharmazeutisches Unternehmen. Das Unternehmen wurde 1929 in Dreux, Frankreich gegründet. Der heutige Firmensitz befindet sich in Paris. Der Deutschlandsitz in München. Das Unternehmen ist im Familienbesitz der Familie Beaufour und beschäftigt rund 4.000 Mitarbeiter. Zu den von Ipsen Group hergestellten Medikamenten gehören unter anderem in der Medikamenten gehören unter anderem in der
, Ipsen adalah perusahaan farmasi Prancis ya … Ipsen adalah perusahaan farmasi Prancis yang berbasis di Paris, Prancis. Perusahaan ini mengkhususkan diri dalam tiga bidang terapi: onkologi, ilmu saraf, dan penyakit langka. Ini diperdagangkan secara publik di Euronext Paris sebagai bagian dari indeks SBF 120 (2005). Ipsen, didirikan oleh Henri Beaufour pada tahun 1929, memiliki lebih dari 5.700 karyawan di seluruh dunia dan memasarkan lebih dari 20 obat di 115 negara.masarkan lebih dari 20 obat di 115 negara.
, Ipsen é uma empresa farmacêutica francesa … Ipsen é uma empresa farmacêutica francesa com sede em Paris, França. Fundamentalmente, desenvolve e comercializa medicamentos usados em oncologia, endocrinologia e no tratamento das doenças neuromusculares. A Ipsen atuava no mercado brasileiro por meio de parceiros distribuidores dos seus medicamentos, contudo, em 2009 a empresa decidiu abrir sua filial em São Paulo visando estreitar os lanços com seus clientes.ndo estreitar os lanços com seus clientes.
, Ipsen es una empresa farmacéutica francesa … Ipsen es una empresa farmacéutica francesa con sede en París, Francia. Se especializa en tres áreas de terapia: oncología, neurociencia y enfermedades raras. Se cotiza en bolsa en Euronext Paris como parte del índice SBF 120 (2005). Ipsen, fundada por Henri Beaufour en 1929, tiene más de 5.700 empleados en todo el mundo y comercializa más de 20 medicamentos en 115 países.iza más de 20 medicamentos en 115 países.
, Ipsen — французская фармацевтическая компа … Ipsen — французская фармацевтическая компания. Штаб-квартира расположена в Булонь-Бийанкур (пригород Парижа, Франция). Специализируется на трех терапевтических областях: онкология, нейробиология и редкие заболевания. Компания продает более 20 лекарств в 115 странах. Семья Бофур, которая занимает 42-е место среди самых богатых семей Франции, по-прежнему владеет 57 % акций и 73 % голосов, а два её члена (внуки основателя Анн Бофур и Анри Бофур) являются членами совета директоров.Бофур) являются членами совета директоров.
|
| rdfs:label |
Ipsen
, イプセン (製薬会社)
, Ipsen Group
|
